Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The study is being conducted to evaluate two doses of TEV-48125 in adult patients with episodic migraine
Epistemonikos ID: cd6c2e1a408d11ead47671ba7f1771cff4793d68
First added on: May 12, 2024